Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial

  1. Lookup NU author(s)
  2. Dr Gareth Veal
Author(s)Veal GJ, Nguyen L, Paci A, Riggi M, Amiel M, Valteau-Couanet D, Brock P, Ladenstein R, Vassal G
Publication type Article
JournalEuropean Journal of Cancer
Year2012
Volume48
Issue16
Pages3063-3072
ISSN (print)0959-8049
ISSN (electronic)1879-0852
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherPergamon
URLhttp://dx.doi.org/10.1016/j.ejca.2012.05.020
DOI10.1016/j.ejca.2012.05.020
Actions    Link to this publication
Share